Search results
Western Union (WU) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
In its upcoming report, Western Union (WU) is predicted by Wall Street analysts to post quarterly earnings of $0.43 per share, reflecting an increase of 2.4% compared to the same period last year
Exploring Analyst Estimates for Ingersoll (IR) Q2 Earnings, Beyond Revenue and EPS
Analysts on Wall Street project that Ingersoll Rand (IR) will announce quarterly earnings of $0.83 per share in its forthcoming report, representing an increase of 3.8% year over year. Revenues are
Monolithic (MPWR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Analysts on Wall Street project that Monolithic Power (MPWR) will announce quarterly earnings of $5.88 per share in its forthcoming report, representing an increase of 39.7% year over year
Unlocking Q2 Potential of Alnylam (ALNY): Exploring Wall Street Estimates for Key Metrics
In its upcoming report, Alnylam Pharmaceuticals (ALNY) is predicted by Wall Street analysts to post quarterly earnings of $2.05 per share, reflecting an increase of 540.6% compared to the same
Ahead of Enterprise Products (EPD) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Analysts on Wall Street project that Enterprise Products Partners (EPD) will announce quarterly earnings of $0.74 per share in its forthcoming report, representing an increase of 12.1% year over
Stay Ahead of the Game With Teva Pharmaceutical Industries (TEVA) Q2 Earnings: Wall Street's Insights on Key Metrics
In its upcoming report, Teva Pharmaceutical Industries Ltd. (TEVA) is predicted by Wall Street analysts to post quarterly earnings of $0.08 per share, reflecting a decline of 87.9% compared to the
CBRE (CBRE) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
In its upcoming report, CBRE Group (CBRE) is predicted by Wall Street analysts to post quarterly earnings of $1.47 per share, reflecting an increase of 23.5% compared to the same period last year
What Analyst Projections for Key Metrics Reveal About GE HealthCare (GEHC) Q2 Earnings
In its upcoming report, GE HealthCare Technologies (GEHC) is predicted by Wall Street analysts to post quarterly earnings of $1.04 per share, reflecting a decline of 1.9% compared to the same
Unveiling HudBay Minerals (HBM) Q2 Outlook: Wall Street Estimates for Key Metrics
Analysts on Wall Street project that HudBay Minerals (HBM) will announce quarterly earnings of $0.31 per share in its forthcoming report, representing an increase of 63.2% year over year. Revenues
Don't Overlook Lamb Weston (LW) International Revenue Trends While Assessing the Stock
Did you analyze how Lamb Weston (LW) fared in its international operations for the quarter ending May 2026? Given the widespread global presence of this frozen foods supplier, scrutinizing the
Is Etsy's Conversational AI the Next Competitive Advantage?
Etsy, Inc. ETSY is taking a meaningful step forward in its artificial intelligence strategy by expanding beyond traditional recommendation engines into conversational experiences that directly
How Levi Strauss Is Building a Faster-Growing DTC Lifestyle Brand
Levi Strauss & Co. LEVI is reshaping its business from a denim-bottoms specialist into a broader direct-to-consumer lifestyle company.The shift is built around stronger digital engagement, wider
3 Top Dividend Stocks to Maximize Your Retirement Income
Believe it or not, seniors fear running out of cash more than they fear dying.
And retirees have good reason to be worried about making their assets last. People are living longer, so that money has
Altimmune’s Pemvidutide Meets Phase II Endpoint in Alcohol Use Disorder Trial
Key Points
- Interested in Altimmune, Inc.? Here are five stocks we like better.
- Altimmune’s Phase II RECLAIM trial met its primary endpoint, with pemvidutide reducing heavy drinking days by
BellRing Brands (BRBR) Expected to Beat Earnings Estimates: Should You Buy?
BellRing Brands (BRBR) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook
Booking Holdings (BKNG) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Booking Holdings (BKNG) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus
BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: Should You Buy?
BridgeBio Pharma (BBIO) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook
Ardent Health, Inc. (ARDT) Expected to Beat Earnings Estimates: Should You Buy?
Ardent Health, Inc. (ARDT) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook
Allegiant Travel (ALGT) Earnings Expected to Grow: Should You Buy?
The market expects Allegiant Travel (ALGT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus
Waters (WAT) Earnings Expected to Grow: Should You Buy?
The market expects Waters (WAT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is


